Insights
Insights From Our Experts
Articles
Current Trends in Medical Review of Promotional and Non-Promotional Materials
Posted by
Michael DeLuca, PharmD, MBA, MSRA , Varun Pandey, PhD , Mary Mehrabian, PharmD, BCGP, BCMAS on March 7, 20243/7/24
Medical Information (MI) plays a crucial role in addressing inquiries from healthcare professionals, payors, and patients/caregivers and ensuring pharmaceutical products’ safe, effective, and appropriate use. However, MI teams often have other important responsibilities beyond the scope…
Future-Proofing Demands Proof: How Innovators Are Transforming Pharma Commercialization
In the fast-evolving landscape of pharmaceuticals, staying ahead demands more than just adapting to today’s challenges – it requires pioneering the future. Introducing intentional innovation, the sweet spot where blue-sky imagination meets on-the-ground effort. It’s being able…
Leveraging the Expertise of Medical Affairs to Create Global Value with Efficient, Cross-functional Collaboration
In the intricate world of pharmaceuticals, the role of Medical Affairs is paramount. Join us as we delve into the crucial elements that drive success in this pivotal function. From strategic alignment to robust data management…
Q&A: Enhanced Protection and Consistency for PRCI in Canada
Introduction At EVERSANA, we’re at the forefront of regulatory work in Canada, and recently, our team has been delving into the realm of PRCI (Public Release of Clinical Information) in Canada and submission Policy 0070 (Regulation…
The Looming Legacy of Software as a Medical Device (SaMD) Misclassification Under Medical Device Directive (MDD)
Regulation (EU) 2017/745, the Medical Device Regulation (MDR), sent shockwaves through the industry with its stricter oversight and transparency demands. While the implementation challenges like delays, notified body capacity, and EUDAMED implementation have dominated discussions, a…
Navigating Successful Partnerships in the Pharmaceutical Industry: Insights from Shorla Oncology CEO Sharon Cunningham
In the ever-evolving landscape of the pharmaceutical industry, forging successful partnerships and collaborations is a cornerstone of achieving groundbreaking advancements and bringing innovative treatments to patients in need. However, navigating through the myriad of advisors, consultants…
Excel in Market Access Success: Key Considerations for Leveraging Your Evidence
Introduction The landscape of launching new medical products presents significant challenges, with a staggering 66% of launches falling short of consensus expectations. Half of these failures are attributed directly to poor market access. Recognizing this, companies…
Empowering Success: EVERSANA’s Value & Evidence Team Guides Clients Through CMS Drug Negotiations Under the Inflation Reduction Act
Authors: Chris Cameron, Kerise Clarke, Barkha Patel, Amanda Griffin In anticipation of CMS’s announcement of the first 10 drugs to be selected for negotiations through the Inflation Reduction Act on September 1, 2023, we partnered to…
CES 2024 Recap – How the Future of Healthcare Will Continue to Be Driven By Innovation & AI
CES 2024, the annual tech conference encompassing everything from cutting-edge gadgets to automotive marvels, healthcare innovations, and futuristic media, left a lasting impression. Amidst the buzz surrounding electric vehicles, transparent screens, and an abundance of massage…
Redefining Field Deployment – Bridging “Share of Voice” with “Share of Influence” for Lasting Impact
In the dynamic realm of pharmaceutical marketing, sales representatives and television commercials remain go-to strategies, skillfully weaving narratives that assure patients of a brand’s therapeutic benefits and persuade providers to alter prescribing habits. Despite their effectiveness,…